Literature DB >> 22132884

Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.

K J Laing1, L Dong, J Sidney, A Sette, D M Koelle.   

Abstract

Herpes virus infections are chronic and co-exist with acquired immune responses that generally prevent severe damage to the host, while allowing periodic shedding of virus and maintenance of its transmission in the community. Herpes simplex viruses type 1 and 2 (HSV-1, HSV-2) are typical in this regard and are representative of the viral subfamily Alphaherpesvirinae, which has a tropism for neuronal and epithelial cells. This review will emphasize recent progress in decoding the physiologically important CD8(+) and CD4(+) T cell responses to HSV in humans. The expanding data set is discussed in the context of the search for an effective HSV vaccine as therapy for existing infections and to prevent new infections.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22132884      PMCID: PMC3248086          DOI: 10.1111/j.1365-2249.2011.04502.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  95 in total

1.  The herpes simplex virus 1 UL17 protein is the second constituent of the capsid vertex-specific component required for DNA packaging and retention.

Authors:  Katerina Toropova; Jamie B Huffman; Fred L Homa; James F Conway
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Knowledge-based virtual screening of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus genome.

Authors:  Jianjun Bi; Huilan Yang; Huacheng Yan; Rengang Song; Jianyong Fan
Journal:  J Theor Biol       Date:  2011-04-22       Impact factor: 2.691

3.  Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.

Authors:  Brian S Sheridan; Thomas L Cherpes; Julie Urban; Pawel Kalinski; Robert L Hendricks
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.

Authors:  William J Muller; Lichun Dong; Adrian Vilalta; Benjamin Byrd; Kai M Wilhelm; Christopher L McClurkan; Michal Margalith; Chao Liu; David Kaslow; John Sidney; Alessandro Sette; David M Koelle
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

5.  Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B.

Authors:  Aziz Alami Chentoufi; Nicholas R Binder; Noureddine Berka; Guillaume Durand; Alex Nguyen; Ilham Bettahi; Bernard Maillère; Lbachir BenMohamed
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

6.  Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency.

Authors:  Jared E Knickelbein; Kamal M Khanna; Michael B Yee; Catherine J Baty; Paul R Kinchington; Robert L Hendricks
Journal:  Science       Date:  2008-10-10       Impact factor: 47.728

7.  Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

Authors:  Min Kim; Janette Taylor; John Sidney; Zorka Mikloska; Neil Bodsworth; Katerina Lagios; Heather Dunckley; Karen Byth-Wilson; Martine Denis; Robert Finlayson; Rajiv Khanna; Alessandro Sette; Anthony L Cunningham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.

Authors:  Richard A Zuckerman; Aldo Lucchetti; William L H Whittington; Jorge Sánchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

9.  HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population.

Authors:  S J Mack; B Tu; A Lazaro; R Yang; A K Lancaster; K Cao; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2008-10-24

10.  An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.

Authors:  Katharine J Looker; Geoffrey P Garnett; George P Schmid
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

View more
  20 in total

1.  Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.

Authors:  Marina Boukhvalova; Jamall McKay; Aissatou Mbaye; Hannah Sanford-Crane; Jorge C G Blanco; Ashley Huber; Betsy C Herold
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

3.  T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.

Authors:  Rachel A Bender Ignacio; Meena S Ramchandani; Kerry J Laing; Christine M Johnston; David M Koelle
Journal:  Viral Immunol       Date:  2016-11-21       Impact factor: 2.257

4.  The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.

Authors:  Joshua O Marshak; Lichun Dong; David M Koelle
Journal:  Methods Mol Biol       Date:  2014

Review 5.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

Review 6.  Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.

Authors:  Jie Zhang; Huan Liu; Bin Wei
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

7.  Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Britnie R James; Sakeen W Kashem; Erik L Brincks; Deepa Rai; Tamara A Kucaba; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 8.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

9.  An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Authors:  Mojca Skoberne; Rhonda Cardin; Alexander Lee; Ana Kazimirova; Veronica Zielinski; Danielle Garvie; Amy Lundberg; Shane Larson; Fernando J Bravo; David I Bernstein; Jessica B Flechtner; Deborah Long
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

10.  Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.

Authors:  Kerry J Laing; Ronnie M Russell; Lichun Dong; D Scott Schmid; Michael Stern; Amalia Magaret; Jürgen G Haas; Christine Johnston; Anna Wald; David M Koelle
Journal:  J Infect Dis       Date:  2015-03-17       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.